Long Shortz with Lumos: FDA approval for FebriDx unlocks billion-dollar opportunity

Lumos Diagnostics receives landmark FDA CLIA waiver approval for its FebriDx point-of-care test. ... Read More The post Long Shortz with Lumos: FDA approval for FebriDx unlocks billion-dollar opportunity appeared first on Stockhead .

Go to News Site